Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azvudine in Hospitalized Moderate to Severe COVID-19 Patients
NCT04668235Phase 3Completed
- Sponsor
- HRH Pharmaceuticals Limited
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azvudine in coronavirus disease 2019 (COVID-19), sponsored by HRH Pharmaceuticals Limited. Started Apr 2021; status: completed.
02
Drugs
azvudine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04668235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668235.